Bridgepoint Health

TCP Awarded Exceptional Grant to Extend its Role as a National Science Facility

Posted on Tuesday January 10, 2017

The Centre for Phenogenomics (TCP), a world class facility that develops mouse models of human diseases, has been awarded a grant of $15.41 million over the next 5 years from the Canada Foundation for Innovation. TCP is jointly operated by Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute and the Research Institute of The Hospital for Sick Children and is Canada’s preeminent research facility for design, generation, and analysis of models of disease including neurodegeneration, cancer, diabetes, and developmental disorders such as autism. Read more »